WILLIAM F. BLEKER, M.D.

Vice President, Medical Safety and Pharmacovigilance

Dr. Bleker joins Sutro Biopharma with over 18 years of experience in drug development including pre- and post-market pharmacovigilance, as well as medical affairs. He received a B.S. in psychobiology from the University of California, Riverside, and M.D. from Xochicalco University in Baja California, Mexico. Prior to joining Sutro, Dr. Bleker served as head of pharmacovigilance and safety risk management at Mirati Therapeutics. At Mirati, he established the pharmacovigilance department and supported the entire Mirati portfolio including the development of their KRAS^G12C Inhibitor, Krazati^TM (adagrasib), from first-in-human study through FDA approval. Prior leadership roles include head of drug safety at Nektar Therapeutics, Santarus where Dr. Bleker contributed to FDA approval of Uceris^® (budesonide), and Hana Biosciences.